$COGT
Cogent Biosciences, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021044445 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $0.00 $530.0K
YoY Change -100.0% -83.11%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.904M $2.800M
YoY Change 75.14% -8.5%
% of Gross Profit
Research & Development $12.39M $5.129M
YoY Change 141.53% -51.69%
% of Gross Profit
Depreciation & Amortization $11.00K $280.0K
YoY Change -96.07% -15.15%
% of Gross Profit
Operating Expenses $12.39M $5.129M
YoY Change 141.53% -51.69%
Operating Profit -$17.29M -$7.403M
YoY Change 133.58% -29.77%
Interest Expense $120.0K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $743.0K $10.00K
YoY Change 7330.0% -60.0%
Pretax Income -$16.55M -$7.390M
YoY Change 123.94% -29.75%
Income Tax
% Of Pretax Income
Net Earnings -$16.55M -$7.393M
YoY Change 123.85% -29.7%
Net Earnings / Revenue -1394.91%
Basic Earnings Per Share -$0.43
Diluted Earnings Per Share -$0.43 -$949.9K
COMMON SHARES
Basic Shares Outstanding 38.44M
Diluted Shares Outstanding 38.44M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $218.1M $21.30M
YoY Change 923.97% -61.9%
Cash & Equivalents $219.4M $22.60M
Short-Term Investments
Other Short-Term Assets $3.245M $2.600M
YoY Change 24.81% 116.67%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $221.4M $23.90M
YoY Change 826.15% -59.21%
LONG-TERM ASSETS
Property, Plant & Equipment $226.0K $5.900M
YoY Change -96.17% 124.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.970M $1.300M
YoY Change 51.54% 53.66%
Total Long-Term Assets $7.166M $7.200M
YoY Change -0.47% -32.77%
TOTAL ASSETS
Total Short-Term Assets $221.4M $23.90M
Total Long-Term Assets $7.166M $7.200M
Total Assets $228.5M $31.10M
YoY Change 634.78% -55.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.992M $600.0K
YoY Change 232.0% -63.86%
Accrued Expenses $7.536M $6.700M
YoY Change 12.48% 4.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.68M $8.300M
YoY Change 64.83% -65.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.031M $3.500M
YoY Change -41.97% -32.69%
Total Long-Term Liabilities $2.031M $3.500M
YoY Change -41.97% -32.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.68M $8.300M
Total Long-Term Liabilities $2.031M $3.500M
Total Liabilities $15.71M $11.80M
YoY Change 33.15% -60.07%
SHAREHOLDERS EQUITY
Retained Earnings -$227.0M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $212.8M $19.24M
YoY Change
Total Liabilities & Shareholders Equity $228.5M $31.10M
YoY Change 634.78% -55.13%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$16.55M -$7.393M
YoY Change 123.85% -29.7%
Depreciation, Depletion And Amortization $11.00K $280.0K
YoY Change -96.07% -15.15%
Cash From Operating Activities -$12.51M -$8.330M
YoY Change 50.14% -26.54%
INVESTING ACTIVITIES
Capital Expenditures -$123.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$123.0K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.000K 70.00K
YoY Change -92.86% -30.0%
NET CHANGE
Cash From Operating Activities -12.51M -8.330M
Cash From Investing Activities -123.0K 0.000
Cash From Financing Activities 5.000K 70.00K
Net Change In Cash -12.63M -8.260M
YoY Change 52.85% 154.94%
FREE CASH FLOW
Cash From Operating Activities -$12.51M -$8.330M
Capital Expenditures -$123.0K $0.00
Free Cash Flow -$12.38M -$8.330M
YoY Change 48.67% -26.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1970000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3245000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
221350000
CY2021Q2 us-gaap Liabilities
Liabilities
15712000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2802000
CY2021Q2 us-gaap Assets
Assets
228516000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5129000
CY2021Q2 cogt Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
6445000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1992000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2031000
CY2021Q2 cogt Contingent Value Right Liability Current
ContingentValueRightLiabilityCurrent
3060000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13681000
us-gaap Costs And Expenses
CostsAndExpenses
21103000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12388000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7403000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30092000
us-gaap Profit Loss
ProfitLoss
-13487000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
31000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
581000
us-gaap Share Based Compensation
ShareBasedCompensation
4371000
us-gaap Share Based Compensation
ShareBasedCompensation
1639000
cogt Noncash Consideration Received From Customer
NoncashConsiderationReceivedFromCustomer
808000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M29D
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3715000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
226000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1255000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4904000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17292000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
120000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2021Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
623000
CY2020Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1227000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000
cogt Change In Fair Value Of Contingent Value Right Liability
ChangeInFairValueOfContingentValueRightLiability
-343000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
743000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1815000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
57000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16549000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7393000
us-gaap Net Income Loss
NetIncomeLoss
-28277000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13487000
us-gaap Net Income Loss
NetIncomeLoss
-13487000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.76
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7655837
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
234667000
CY2021Q1 cogt Issuance Of Common Stock Value To Settle Liability
IssuanceOfCommonStockValueToSettleLiability
2043000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
260000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1521000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11728000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2590000
us-gaap Costs And Expenses
CostsAndExpenses
30092000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13544000
us-gaap Investment Income Interest
InvestmentIncomeInterest
245000
us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
17292000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
7931000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
212804000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
31762000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
38000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
35000
CY2020Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
808000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
507000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6094000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
25702000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
870000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7393000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
19241000
us-gaap Profit Loss
ProfitLoss
-28277000
cogt Change In Fair Value Of Contingent Value Right Liability
ChangeInFairValueOfContingentValueRightLiability
-343000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
523000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1440000
cogt Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-900000
cogt Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-718000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1970000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-427000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1260000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2551000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1666000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1504000
cogt Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-992000
cogt Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-789000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1003000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23877000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16217000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
35000
cogt Payment To Contingent Value Right Holders
PaymentToContingentValueRightHolders
85000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
135000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24085000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16082000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243445000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38679000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219360000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22597000
us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
25481000
us-gaap Stock Issued1
StockIssued1
2043000
us-gaap Net Income Loss
NetIncomeLoss
-28300000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227000000.0
us-gaap Operating Lease Cost
OperatingLeaseCost
1200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#222222;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:8pt;text-indent:4.54%;color:#222222;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses, the valuation of the CVR liability and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates, as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.</p>
CY2020Q3 us-gaap Share Price
SharePrice
8.80
CY2021Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0
CY2021Q2 cogt Fair Value Assets Transfers Between Level One Two And Three
FairValueAssetsTransfersBetweenLevelOneTwoAndThree
0
CY2021Q2 cogt Fair Value Assets Transfers Between Level One Two And Three
FairValueAssetsTransfersBetweenLevelOneTwoAndThree
0
CY2020Q2 cogt Fair Value Assets Transfers Between Level One Two And Three
FairValueAssetsTransfersBetweenLevelOneTwoAndThree
0
CY2020Q2 cogt Fair Value Assets Transfers Between Level One Two And Three
FairValueAssetsTransfersBetweenLevelOneTwoAndThree
0
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1262000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1443000
CY2021Q2 cogt Accrued External Research And Development Expenses Current
AccruedExternalResearchAndDevelopmentExpensesCurrent
2415000
CY2020Q4 cogt Accrued External Research And Development Expenses Current
AccruedExternalResearchAndDevelopmentExpensesCurrent
2191000
CY2021Q2 cogt Accrued External Manufacturing Cost Current
AccruedExternalManufacturingCostCurrent
1675000
CY2020Q4 cogt Accrued External Manufacturing Cost Current
AccruedExternalManufacturingCostCurrent
161000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1093000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
984000
CY2021Q2 cogt Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
6445000
CY2020Q4 cogt Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
4779000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 cogt Preferred Stock Including Temporary Equity Shares Authorized
PreferredStockIncludingTemporaryEquitySharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42390225
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2590000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
870000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4371000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1639000
cogt Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2023-04
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the Company’s option to extend for an additional five-year term.
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
900000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
900000
us-gaap Variable Lease Cost
VariableLeaseCost
403000
us-gaap Sublease Income
SubleaseIncome
1227000
us-gaap Lease Cost
LeaseCost
376000
us-gaap Operating Lease Payments
OperatingLeasePayments
1604000
CY2021Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0950
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1224000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2497000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
841000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4562000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
347000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4215000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2184000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2031000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4215000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16549000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7393000
us-gaap Net Income Loss
NetIncomeLoss
-28277000
us-gaap Net Income Loss
NetIncomeLoss
-13487000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16549000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7393000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28277000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13487000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38441729
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7777487
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36670353
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7655837
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.76
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33573618
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
869427
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
CY2020Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0

Files In Submission

Name View Source Status
0001564590-21-044445-index-headers.html Edgar Link pending
0001564590-21-044445-index.html Edgar Link pending
0001564590-21-044445.txt Edgar Link pending
0001564590-21-044445-xbrl.zip Edgar Link pending
cogt-10q_20210630.htm Edgar Link pending
cogt-10q_20210630_htm.xml Edgar Link completed
cogt-20210630.xsd Edgar Link pending
cogt-20210630_cal.xml Edgar Link unprocessable
cogt-20210630_def.xml Edgar Link unprocessable
cogt-20210630_lab.xml Edgar Link unprocessable
cogt-20210630_pre.xml Edgar Link unprocessable
cogt-ex311_8.htm Edgar Link pending
cogt-ex312_9.htm Edgar Link pending
cogt-ex321_6.htm Edgar Link pending
cogt-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending